Sirius Therapeutics Co., Ltd.

This early-stage study is testing a new injectable drug called SRSD216 in people with high levels of lipoprotein(a), a type of fat in the blood linked to heart disease risk. The main goals are to check if the drug is safe and well-tolerated, and to see how it affects lipoprotein(…

This study is testing whether a new drug called SRSD107 works as well as the standard medication (enoxaparin) at preventing dangerous blood clots after knee replacement surgery. About 450 adults aged 60-80 having elective knee surgery will participate. Researchers will compare th…